Navigation Links
The American Liver Foundation Encourages Heightened Awareness of Hepatitis B and C in Light of Recent Events in the News
Date:11/21/2007

NEW YORK, Nov. 21 /PRNewswire-USNewswire/ -- The following release and statements are attributed to The American Liver Foundation: The American Liver Foundation, a nonprofit organization dedicated to raising awareness and improving the quality of life for the 30 million Americans with liver disease, issued a statement today expressing its concern over the recent reports that Nassau County physician Dr. Harvey Finkelstein made repeated use of medicine vials intended for single-patient use, potentially contaminating the vials.

"What is tragic about this situation," said Dr. Douglas Dieterich, Professor of Medicine, Liver Diseases, Mount Sinai School of Medicine and Chairman of the Board of the Greater New York City Chapter of ALF, "is that innocent people are now at risk of contracting potentially deadly viruses: hepatitis B, hepatitis C, and HIV.

Although most Americans are familiar with HIV, most do not know about hepatitis B and C, the two most common forms of chronic liver disease. Hepatitis B is 100 times more infectious and hepatitis C four times more infectious than HIV. More than 5 million Americans have hepatitis B or C. Viral hepatitis exhibits few if any symptoms, and the undetected illness can progress to a point where treatment may no longer be effective. These viral infections can lead to cirrhosis, liver cancer and death if untreated.

"When it comes to hepatitis, for example, many doctors don't know how it is transmitted or when to test their patients," said Dieterich. "Testing can allow for early diagnosis and treatment, preventing the virus from developing into cirrhosis of the liver or cancer."

Although hepatitis B is vaccine-preventable, there is no complete cure for those already infected. And while hepatitis C can be treated successfully for half of those infected, there is no vaccine to protect the uninfected. Hepatitis B and C infection can be avoided by using only sterile needles for tattoos or body piercing, avoiding injection drugs, and practicing safer sex.

"ALF works on many fronts in order to combat liver disease," said Rick Smith, the President and CEO of the American Liver Foundation. "Unfortunately, one of the greatest obstacles to overcoming liver disease is the ignorance and the stigma attached to it. That is why we provide medical seminars for physicians as well as awareness campaigns for the general public."

About the American Liver Foundation

The American Liver Foundation is the nation's leading nonprofit organization promoting liver health and disease prevention. ALF provides research, education and advocacy for those affected by liver-related diseases including hepatitis. Please visit the American Liver Foundation's Web site at http://www.liverfoundation.org.


'/>"/>
SOURCE American Liver Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. American Red Cross and FedEx Announce Collaboration to Help Small Businesses Get Prepared for Disaster
10. This October, the American Physical Therapy Associations National Physical Therapy Month to Focus on Nations Obesity Epidemic
11. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating up and the ... business owners should be aware that the summer months provide more than warmer temperatures ... and keys can be negatively affected from direct exposure to the sun. When it ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... By scoring 100% for ... consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's work as ... of all charities reviewed by Charity Navigator and earns ANRF a spot on their ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet ... , But how often do ophthalmologists and optometrists in Sweden recommend the use of ... with early symptoms of AMD? A study published recently in Dove Medical ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... in Newburgh, New York, has recently begun offering three new minimally invasive procedures ... best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited to bring microneedling, ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
Breaking Medicine Technology: